Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01208766
Show Display Options
Rank Status Study
1 Active, not recruiting Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib, Melphalan, Prednisone (VMP);   Drug: 1 or 2 cycle(s) HDM (High Dose Melphalan);   Drug: 2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)

Study has passed its completion date and status has not been verified in more than two years.